Formulation and biopharmaceutical evaluation of osmotic matrix tablets of diclofenac sodium

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 11, Issue 4, 2004, Pages 263-270

  Rani, Meena ^a   Surana, Rahul ^a   Sankar, C ^a   Mishra, B ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Bioavailability; Controlled Release; Diclofenac Sodium; Osmotic Matrix Tablets; Pharmacokinetic Parameters

Indexed keywords

CELLULOSE ACETATE; DICLOFENAC; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 400; TRIACETIN; VOVERAN SR;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED DRUG RELEASE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COATING; DRUG FORMULATION; DRUG SOLUBILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; MATRIX TABLET; NORMAL HUMAN; OSMOSIS; OSMOTIC MATRIX TABLET; PRIORITY JOURNAL; SURFACE PROPERTY; TABLET MANUFACTURE;

ADULT; BIOPHARMACEUTICS; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; DICLOFENAC; DRUG EVALUATION; FEMALE; HUMANS; MALE; OSMOSIS; TABLETS, ENTERIC-COATED;

EID: 4143050612     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/10717540490467393     Document Type: Article

References (18)

1. Bettini, R.,Catellani, P. L., and Colombo, P. 1996. Osmotic matrix for controlled drug delivery. Proc. Int. Symp. Contr. Rel. Bioact. Mater. 23:55-56.
2. Catellani, P. L., Colombo, P., Peppas, N. A., Santi, P., and Bettini, R. 1998. Partial permselective coating adds an osmotic contribution to drug release from swellable matrix. J. Pharm. Sci. 87:726-730.
3. Garcia-Encina, G., Torres, D., Seijo, B., and Vila Jato, J. L. 1995. Formulation and in vitro evaluation of HPMCP-microencapsulated drug-resin complexes for sustained release of diclofenac. Int. J. Pharm. 121:239-243.
4. Giagoudakis, G., and Markantonis, S. L. 1998. An alternative high-performance liquid chromatographic method for the determination of diclofenac and flurbiprofen in plasma. J. Pharm. Biomed. Anal. 17:897-901.
5. Hosny, E. A., Al-Helw, A. R. M., and Al-Dardiri, M. A. 1997. Comparative study of in vitro release and bioavailability of sustained release diclofenac sodium from certain hydrophilic polymers and commercial tablets in beagle dogs. Pharm. Acta Helv. 72:159-164.
6. Hui, X., Hewitt, P. G., Poblete, N., Maibach, H. I., Shainhouse, J. Z., and Wester, R. C. 1998. In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers. Pharm. Res. 15:1589-1595.
7. Lee, V. H. L., and Robinson, J. R. 1987. Controlled Drug Delivery: Fundamentals and Applications, 2nd ed. New York: Marcel Dekker.
8. Liu, C. H., Kao, Y. H., Chen, S. C., Sokoloski, T D., and Sheu, M. T 1995. In vitro and in vivo studies of the diclofenac sodium controlled-release matrix tablets. J. Pharm. Pharmacol. 47:360-364.
9. Mishra, B., Panyam, J., and Sharma, A. V. 1999. In vitro release of diclofenac sodium from multiple emulsions; effect of location of drug and pH of the aqueous phase. Acta Pharm. Turc. 41:42-45.
10. Nishihata, T. 1987. Simple formulation of sustained-release tablets of sodium diclofenac and examination in humans. Int. J. Pharm. 40:125-128.
11. Rani, M., and Mishra, B. 2001a. Comparative evaluation of in vitro performance of commercial and fabricated sustained release diclofenac sodium tablets. Ind. J. Pharm. Sci. 63:247-250.
12. Rani, M., and Mishra, B. 2001b. Effect of admixed polymers on diclofenac sodium release from matrix tablets. Pharm. Pharmacol. Lett. 11:76-78.
13. Rani, M., and Mishra, B. 2003. Development and evaluation of carbomer based matrices for the controlled delivery of diclofenac sodium. Acta Pharm. Turc. 45:5-10.
14. Reiss, W., Sterlin, H., Degen, P., Faigle, J. W., Gerardin, A., Moppert, J., Sallman, A., Schmin, A., Schweizer, A., Sule, M., Thesbald, W., and Wagner, J. 1978. Pharmacokinetics and metabolism of the anti-inflammatory agent voltaren. Scan. J. Rheumatol. 22:17-29.
15. Ritger, P. L., and Peppas, N. A. 1987. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Contr. Rel. 5:37-42.
16. Sajeev, C., Vinay, G., Archna, R., and Saha, R. N. 2002. Oral controlled release formulation of diclofenac sodium by microencapsulation with ethyl cellulose. J. Microencap. 19:753-760.
17. Sankar, C., Rani, M., Srivastava, A. K., and Mishra, B. 2001. Chitosan based Pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation. Pharmazie 56:223-226.
18. United States Pharmacopoeia 24. 2001. Rockville, MD: United States Pharmacopoeial Convention, p. 2051.